Showing results (61-70 of 109) with videos related to
Sort By:
Pageof 11
The American Journal of Pathology|March 10, 2001
Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladderA Ristimäki, O Nieminen, K Saukkonen, et al.British Journal of Cancer|April 1, 1995
Preoperative serum levels of CEA and CA 242 in colorectal cancerM Carpelan-Holmström, C Haglund, P Kuusela, et al.Journal of Clinical Pathology|March 1, 2005
Tenascin-C in primary Merkel cell carcinomaV Koljonen, T Jahkola, E Tukiainen, et al.British Journal of Cancer|August 1, 1987
Tumour-associated trypsin inhibitor (TATI) in human ovarian cyst fluid. Comparison with CA 125 and CEAH Halila, M L Huhtala, C Haglund, et al.Anticancer Research|November 1, 1995
Prognostic value of Ki-67 expression, ploidy and S-phase fraction in patients with pancreatic cancerJ Lundin, S Nordling, K von Boguslawsky, et al.Oncology|March 1, 1996
Prognostic value of immunohistochemical expression of p53 in patients with pancreatic cancerJ Lundin, S Nordling, K von Boguslawsky, et al.Endocrine-Related Cancer|July 31, 2009
High frequency of SNAIL-expressing cells confirms and predicts metastatic potential of phaeochromocytomaV Häyry, K Salmenkivi, J Arola, et al.Journal of Clinical Pathology|May 30, 2006
MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancerJ Mrena, J-P Wiksten, S Nordling, et al.Biology of the Neonate|February 25, 2006
Consistent expression of HGF and c-met in the perinatal lungP Lassus, J Janer, C Haglund, et al.Clinical Chemistry|October 3, 1999
Time-resolved immunofluorometric assay of trypsin-1 complexed with alpha(1)-antitrypsin in serum: increased immunoreactivity in patients with biliary tract cancerJ Hedström, C Haglund, E Kemppainen, et al.Pageof 11